These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 11083284

  • 1. Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli.
    Nieuwenhuis EE, Visser MR, Kavelaars A, Cobelens PM, Fleer A, Harmsen W, Verhoef J, Akkermans LM, Heijnen CJ.
    Arthritis Rheum; 2000 Nov; 43(11):2583-9. PubMed ID: 11083284
    [Abstract] [Full Text] [Related]

  • 2. Treatment of adjuvant-induced arthritis by oral administration of mycobacterial Hsp65 during disease.
    Cobelens PM, Heijnen CJ, Nieuwenhuis EE, Kramer PP, van der Zee R, van Eden W, Kavelaars A.
    Arthritis Rheum; 2000 Dec; 43(12):2694-702. PubMed ID: 11145027
    [Abstract] [Full Text] [Related]

  • 3. Oral testosterone in male rats and the development of experimental autoimmune encephalomyelitis.
    Macció DR, Calfa G, Roth GA.
    Neuroimmunomodulation; 2005 Dec; 12(4):246-54. PubMed ID: 15990455
    [Abstract] [Full Text] [Related]

  • 4. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.
    Haruna Y, Morita Y, Yada T, Satoh M, Fox DA, Kashihara N.
    Arthritis Rheum; 2007 Jun; 56(6):1827-35. PubMed ID: 17530711
    [Abstract] [Full Text] [Related]

  • 5. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation.
    Webster EL, Barrientos RM, Contoreggi C, Isaac MG, Ligier S, Gabry KE, Chrousos GP, McCarthy EF, Rice KC, Gold PW, Sternberg EM.
    J Rheumatol; 2002 Jun; 29(6):1252-61. PubMed ID: 12064844
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis.
    Lange F, Bajtner E, Rintisch C, Nandakumar KS, Sack U, Holmdahl R.
    Ann Rheum Dis; 2005 Apr; 64(4):599-605. PubMed ID: 15345503
    [Abstract] [Full Text] [Related]

  • 7. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ, Hur M, Kim YL, Lee GH, Kim J, Kim I, Lee M, Han HK, Kim MS, Hwang S, Kim S, Woo AM, Yoon Y, Park HJ, Won J.
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
    [Abstract] [Full Text] [Related]

  • 8. Reactivation of antigen-induced arthritis in mice by oral administration of lipopolysaccharide.
    Yoshino S, Yamaki K, Taneda S, Yanagisawa R, Takano H.
    Scand J Immunol; 2005 Aug; 62(2):117-22. PubMed ID: 16101817
    [Abstract] [Full Text] [Related]

  • 9. Suppressive effects of QFGJS, a preparation from an anti-arthritic herbal formula, on rat experimental adjuvant-induced arthritis.
    Cai X, Zhou H, Wong YF, Xie Y, Liu ZQ, Jiang ZH, Bian ZX, Xu HX, Liu L.
    Biochem Biophys Res Commun; 2005 Nov 18; 337(2):586-94. PubMed ID: 16199007
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.
    Prakken BJ, Roord S, van Kooten PJ, Wagenaar JP, van Eden W, Albani S, Wauben MH.
    Arthritis Rheum; 2002 Jul 18; 46(7):1937-46. PubMed ID: 12124879
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
    Magari K, Miyata S, Nishigaki F, Ohkubo Y, Mutoh S, Goto T.
    J Rheumatol; 2003 Oct 18; 30(10):2193-200. PubMed ID: 14528517
    [Abstract] [Full Text] [Related]

  • 12. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
    Milicevic I, Pekovic S, Subasic S, Mostarica-Stojkovic M, Stosic-Grujicic S, Medic-Mijacevic L, Pejanovic V, Rakic L, Stojiljkovic M.
    J Neurosci Res; 2003 Apr 15; 72(2):268-78. PubMed ID: 12672002
    [Abstract] [Full Text] [Related]

  • 13. M2000: a revolution in pharmacology.
    Mirshafiey A, Cuzzocrea S, Rehm BH, Matsuo H.
    Med Sci Monit; 2005 Aug 15; 11(8):PI53-63. PubMed ID: 16049391
    [Abstract] [Full Text] [Related]

  • 14. Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis.
    Bendele AM, Chlipala ES, Scherrer J, Frazier J, Sennello G, Rich WJ, Edwards CK.
    Arthritis Rheum; 2000 Dec 15; 43(12):2648-59. PubMed ID: 11145022
    [Abstract] [Full Text] [Related]

  • 15. Neurointermediate pituitary lobectomy decreases the incidence and severity of experimental autoimmune encephalomyelitis in Lewis rats.
    Quintanar-Stephano A, Chavira-Ramírez R, Kovacs K, Berczi I.
    J Endocrinol; 2005 Jan 15; 184(1):51-8. PubMed ID: 15642782
    [Abstract] [Full Text] [Related]

  • 16. Antiarthritic effects of relaxin, in combination with estrogen, in rat adjuvant-induced arthritis.
    Santora K, Rasa C, Visco D, Steinetz BG, Bagnell CA.
    J Pharmacol Exp Ther; 2007 Aug 15; 322(2):887-93. PubMed ID: 17526806
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
    Li XB, Schluesener HJ.
    Arch Immunol Ther Exp (Warsz); 2006 Aug 15; 54(1):51-3. PubMed ID: 16642257
    [Abstract] [Full Text] [Related]

  • 18. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D, Aharoni R, Klinger E, Kreitman R, Raymond E, Malley A, Shofti R, Sela M, Arnon R.
    Ann N Y Acad Sci; 2004 Dec 15; 1029():239-49. PubMed ID: 15681762
    [Abstract] [Full Text] [Related]

  • 19. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes.
    Metselaar JM, Wauben MH, Wagenaar-Hilbers JP, Boerman OC, Storm G.
    Arthritis Rheum; 2003 Jul 15; 48(7):2059-66. PubMed ID: 12847701
    [Abstract] [Full Text] [Related]

  • 20. Effects of the new immunoactive compound FCE 20696 on rat and murine models of autoimmune diseases.
    Isetta AM, Ferrari M, Fornasiero MC, Trizio D.
    Immunopharmacol Immunotoxicol; 1991 Jul 15; 13(4):499-511. PubMed ID: 1774434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.